{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,5]],"date-time":"2024-07-05T00:18:41Z","timestamp":1720138721584},"reference-count":18,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,7,3]]},"DOI":"10.7759\/cureus.63777","type":"journal-article","created":{"date-parts":[[2024,7,4]],"date-time":"2024-07-04T03:07:53Z","timestamp":1720062473000},"source":"Crossref","is-referenced-by-count":0,"title":["A Case of Revelation Due to Pegfilgrastim"],"prefix":"10.7759","author":[{"given":"Kevin T","family":"Dao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kishan","family":"Ghadiya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elias","family":"Inga Jaco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rupam","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roshun","family":"Rahimi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marah","family":"Sukkar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Moujin","family":"Adebayo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janpreet","family":"Bhandohal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harmanjeet","family":"Dhillon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fowrooz","family":"Joolhar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1188\/03.CJON.55-56","article-title":"Pegfilgrastim for chemotherapy-induced neutropenia","volume":"7","author":"Bedell C","year":"2003","unstructured":"Bedell C. Pegfilgrastim for chemotherapy-induced neutropenia. Clin J Oncol Nurs. 2003, 7:55-6, 63-4. 10.1188\/03.CJON.55-56","journal-title":"Clin J Oncol Nurs"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.2165\/11586040-000000000-00000","article-title":"Pharmacokinetics and pharmacodynamics of pegfilgrastim","volume":"50","author":"Yang BB","year":"2011","unstructured":"Yang BB, Kido A. Pharmacokinetics and pharmacodynamics of pegfilgrastim. Clin Pharmacokinet. 2011, 50:295-306. 10.2165\/11586040-000000000-00000","journal-title":"Clin Pharmacokinet"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/s1470-2045(04)01536-0","article-title":"Pegfilgrastim lowers side-effects of chemotherapy","volume":"5","author":"Sharma DC","year":"2004","unstructured":"Sharma DC. Pegfilgrastim lowers side-effects of chemotherapy. The Lancet Oncology. 2004, 5:8. 10.1016\/s1470-2045(04)01536-0","journal-title":"The Lancet Oncology"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2015.62.3488","article-title":"Recommendations for the use of WBC growth factors: American Society of Clinical Oncology clinical practice guideline update","volume":"33","author":"Smith TJ","year":"2015","unstructured":"Smith TJ, Bohlke K, Lyman GH, et al.. Recommendations for the use of WBC growth factors: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol. 2015, 33:3199-212. 10.1200\/JCO.2015.62.3488","journal-title":"J Clin Oncol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctarc.2021.100466","article-title":"Use of prophylactic pegfilgrastim for chemotherapy-induced neutropenia in the US: a review of adherence to present guidelines for usage","volume":"29","author":"Crawford J","year":"2021","unstructured":"Crawford J, Moore DC, Morrison VA, Dale D. Use of prophylactic pegfilgrastim for chemotherapy-induced neutropenia in the US: a review of adherence to present guidelines for usage. Cancer Treat Res Commun. 2021, 29:100466. 10.1016\/j.ctarc.2021.100466","journal-title":"Cancer Treat Res Commun"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-021-08197-6","article-title":"Comparing the efficacy and side-effects of PDLASTA\u00ae (Pegfilgrastim) with PDGRASTIM\u00ae (Filgrastim) in breast cancer patients: a non-inferiority randomized clinical trial","volume":"21","author":"Najafi S","year":"2021","unstructured":"Najafi S, Ansari M, Kaveh V, Haghighat S. Comparing the efficacy and side-effects of PDLASTA\u00ae (Pegfilgrastim) with PDGRASTIM\u00ae (Filgrastim) in breast cancer patients: a non-inferiority randomized clinical trial. BMC Cancer. 2021, 21:454. 10.1186\/s12885-021-08197-6","journal-title":"BMC Cancer"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1177\/1060028017706373","article-title":"Pegfilgrastim-induced bone pain: a review on incidence, risk factors, and evidence-based management","volume":"51","author":"Moore DC","year":"2017","unstructured":"Moore DC, Pellegrino AE. Pegfilgrastim-induced bone pain: a review on incidence, risk factors, and evidence-based management. Ann Pharmacother. 2017, 51:797-803. 10.1177\/1060028017706373","journal-title":"Ann Pharmacother"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2021-243757","article-title":"Pegfilgrastim-induced large vessel vasculitis","volume":"14","author":"Saito H","year":"2021","unstructured":"Saito H, Suda T, Oishi N, Matsushita E. Pegfilgrastim-induced large vessel vasculitis. BMJ Case Rep. 2021, 14:e243757. 10.1136\/bcr-2021-243757","journal-title":"BMJ Case Rep"},{"key":"ref9","article-title":"Large-vessel vasculitis induced by pegfilgrastim","volume":"46","author":"Costa Silva R","year":"2021","unstructured":"Costa Silva R, Monteiro M, Dias RP, et al.. Large-vessel vasculitis induced by pegfilgrastim. Acta Reumatol Port. 2021, 46:355-9.","journal-title":"Acta Reumatol Port"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1345\/aph.1K093","article-title":"Pegfilgrastim-induced hyperleukocytosis","volume":"41","author":"Snyder RL","year":"2007","unstructured":"Snyder RL, Stringham DJ. Pegfilgrastim-induced hyperleukocytosis. Ann Pharmacother. 2007, 41:1524-30. 10.1345\/aph.1K093","journal-title":"Ann Pharmacother"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.11882","article-title":"Chemotherapy-induced neutropenia: risks, consequences, and new directions for its management","volume":"100","author":"Crawford J","year":"2004","unstructured":"Crawford J, Dale DC, Lyman GH. Chemotherapy-induced neutropenia: risks, consequences, and new directions for its management. Cancer. 2004, 100:228-37. 10.1002\/cncr.11882","journal-title":"Cancer"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.202004-1116TR","article-title":"Sepsis and cancer: an interplay of friends and foes","volume":"202","author":"Mirouse A","year":"2020","unstructured":"Mirouse A, Vigneron C, Llitjos JF, et al.. Sepsis and cancer: an interplay of friends and foes. Am J Respir Crit Care Med. 2020, 202:1625-35. 10.1164\/rccm.202004-1116TR","journal-title":"Am J Respir Crit Care Med"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2020-038349","article-title":"Sepsis in patients with haematological versus solid cancer: a retrospective cohort study","volume":"11","author":"Bou Chebl R","year":"2021","unstructured":"Bou Chebl R, Safa R, Sabra M, et al.. Sepsis in patients with haematological versus solid cancer: a retrospective cohort study. BMJ Open. 2021, 11:e038349. 10.1136\/bmjopen-2020-038349","journal-title":"BMJ Open"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1002\/joa3.12326","article-title":"Cardiac implantable electronic device infection: does the device need to be extracted?","volume":"36","author":"Nagarakanti S","year":"2020","unstructured":"Nagarakanti S, Bishburg E, Bapat A. Cardiac implantable electronic device infection: does the device need to be extracted?. J Arrhythm. 2020, 36:493-7. 10.1002\/joa3.12326","journal-title":"J Arrhythm"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2007.01.072","article-title":"Management and outcome of permanent pacemaker and implantable cardioverter-defibrillator infections","volume":"49","author":"Sohail MR","year":"2007","unstructured":"Sohail MR, Uslan DZ, Khan AH, et al.. Management and outcome of permanent pacemaker and implantable cardioverter-defibrillator infections. J Am Coll Cardiol. 2007, 49:1851-9. 10.1016\/j.jacc.2007.01.072","journal-title":"J Am Coll Cardiol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1901111","article-title":"Antibacterial envelope to prevent cardiac implantable device infection","volume":"380","author":"Tarakji KG","year":"2019","unstructured":"Tarakji KG, Mittal S, Kennergren C, et al.. Antibacterial envelope to prevent cardiac implantable device infection. N Engl J Med. 2019, 380:1895-905. 10.1056\/NEJMoa1901111","journal-title":"N Engl J Med"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1136\/hrt.72.4.339","article-title":"Antibiotic prophylaxis in permanent pacemaker implantation: a prospective randomised trial","volume":"72","author":"Mounsey JP","year":"1994","unstructured":"Mounsey JP, Griffith MJ, Tynan M, Gould FK, MacDermott AF, Gold RG, Bexton RS. Antibiotic prophylaxis in permanent pacemaker implantation: a prospective randomised trial. Br Heart J. 1994, 72:339-43. 10.1136\/hrt.72.4.339","journal-title":"Br Heart J"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.3109\/14017438409109896","article-title":"Antibiotic prophylaxis in pacemaker surgery--a prospective study","volume":"18","author":"Bluhm G","year":"1984","unstructured":"Bluhm G, Jacobson B, Julander I, Levander-Lindgren M, Olin C. Antibiotic prophylaxis in pacemaker surgery--a prospective study. Scand J Thorac Cardiovasc Surg. 1984, 18:227-34. 10.3109\/14017438409109896","journal-title":"Scand J Thorac Cardiovasc Surg"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/270045-a-case-of-revelation-due-to-pegfilgrastim","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,4]],"date-time":"2024-07-04T03:07:59Z","timestamp":1720062479000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/270045-a-case-of-revelation-due-to-pegfilgrastim"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,3]]},"references-count":18,"URL":"https:\/\/doi.org\/10.7759\/cureus.63777","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7,3]]}}}